Institute of Militalry Medicine, Nanjing Command,Nanjing, 210002, China;
Department of Medical Management, Hohai University, Nanjing, 210024, China;
Department of Epidemiology and Biostatistics, School of Public Health,Nanjing Medical University, Nanjing, 210029, China;
Institute of Militalry Medicine, Nanjing Command,Nanjing, 210002, China;
Department of Epidemiology and Biostatistics, School of Public Health,Nanjing Medical University, Nanjing, 210029, China;
Institute of Militalry Medicine, Nanjing Command,Nanjing, 210002, China;
Department of Epidemiology and Biostatistics, School of Public Health,Nanjing Medical University, Nanjing, 210029, China;
Institute of Militalry Medicine, Nanjing Command,Nanjing, 210002, China;
hepatitis C virus (HCV); genotypes; F protein; hcv persistent infection; HCV selflimiting infection;
机译:丙型肝炎病毒(HCV)感染和HCV /人类免疫缺陷病毒合并感染的注射吸毒者的管理和治疗。
机译:丙型肝炎病毒(HCV)感染以及被HCV和HIV / HCV感染的注射吸毒者重新感染
机译:伊朗注射吸毒者中丙型肝炎病毒的分子流行病学:随着时间的流逝,HCV基因型的流行率略有变化
机译:丙型肝炎病毒基因型和F蛋白对注射药物HCV感染结果的影响
机译:中国南部注射吸毒者的丙型肝炎感染:病毒清除率低,多种基因型和混合基因型感染。
机译:丙型肝炎病毒(HCV)感染以及被HCV和HIV / HCV感染的注射吸毒者重新感染
机译:丙型肝炎病毒(HCV)感染以及被HCV和HIV / HCV感染的注射吸毒者重新感染